[1]
|
(2020) The Species Severe Acute Respiratory Syndrome-Related Coronavirus: Classifying 2019-NCoV and Naming It SARS-CoV-2. Nature Microbiology, 5, 536-544. https://doi.org/10.1038/s41564-020-0695-z
|
[2]
|
Niu, P.H., Yang, B., Wu, H.L., et al. (2020) Genomiccharacterisation and Epidemiology of 2019 Novel Coronavirus: Implications for Virus Origins and Receptor Binding. The Lancet (London, England), 395, 565-574.
https://doi.org/10.1016/S0140-6736(20)30251-8
|
[3]
|
Peng, Z., Lou, X.Y., Guang, X.W., et al. (2020) A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin. Nature, 579, 270-273. https://doi.org/10.1038/s41586-020-2012-7
|
[4]
|
Atzrodt, C.L., Maknojia, I., Mccarthy, R.D.P., et al. (2020) A Guide to COVID-19: A Global Pandemic Caused by the Novel Coronavirus SARS-CoV-2. The FEBS Journal, 287, 3633-3650. https://doi.org/10.1111/febs.15375
|
[5]
|
Guan, W.J., Ni, Z.Y., Hu, Y., et al. (2020) Clinical Characteristics of Coronavirus Disease 2019 in China. The New England Journal of Medicine, 382, 1708-1720.
|
[6]
|
Onder, G., Rezza, G. and Brusaferro, S. (2020) Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA, 323, 1775-1776. https://doi.org/10.1001/jama.2020.4683
|
[7]
|
Epidemiology Working Group for NCIP Epidemic Response (2020) The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) in China. Chinese Journal of Epidemiology, 41, 145-151.
https://doi.org/10.46234/ccdcw2020.032
|
[8]
|
Mao, L., Jin, H., Wang, M., et al. (2020) Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurology, 77, 683-690. https://doi.org/10.1001/jamaneurol.2020.1127
|
[9]
|
(2021) Global Prevalence and Burden of Depressive and Anxiety Dis-orders in 204 Countries and Territories in 2020 Due to the COVID-19 Pandemic. The Lancet (London, England), 398, 1700-1712.
|
[10]
|
Lechien, J.R., Chiesa-Estomba, C.M., Hans, S., Barillari, M.R., Jouffe, L. and Saussez, S. (2020) Loss of Smell and Taste in 2013 European Patients with Mild to Moderate COVID-19. Annals of Internal Medicine, 173, 672-675.
https://doi.org/10.7326/M20-2428
|
[11]
|
(2020) Prevalence of Chemosensory Dysfunction in COVID-19 Patients: A Sys-tematic Review and Meta-Analysis Reveals Significant Ethnic Differences. ACS Chemical Neuroscience, 11, 2944-2961.
|
[12]
|
Butowt, R. and Von Bartheld, C.S. (2020) Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection. The Neuroscientist: A Review Journal Bringing Neurobiology, Neurology and Psychi-atry, 27, 582-603. https://doi.org/10.1177/1073858420956905
|
[13]
|
Benetti, E., Tita, R., Spiga, O., Ciolfi, A., Birolo, G., Bruselles, A., et al. (2020) ACE2 Gene Variants May Underlie Interindividual Variability and Susceptibility to COVID-19 in the Italian Population. European Journal of Human Genetics: EJHG, 28, 1602-1614. https://doi.org/10.1038/s41431-020-0691-z
|
[14]
|
Cao, Y.N., Li, L., Feng, Z.M., Wan, S.Q., Huang, P.D., Sun, X.H., et al. (2020) Comparative Genetic Analysis of the Novel Coronavirus (2019-NCoV/SARS-CoV-2) Receptor ACE2 in Different Populations. Cell Discovery, 6, Article No. 11. https://doi.org/10.1038/s41421-020-0147-1
|
[15]
|
Lechien, J.R., Chiesa-Estomba, C.M., De Siati, D.R., Horoi, M., Le Bon, S.D., Rodriguez, A., et al. (2020) Olfactory and Gustatory Dysfunc-tions as a Clinical Presentation of Mild-to-Moderate Forms of the Coronavirus Disease (COVID-19): A Multicenter European Study. European Archives of Oto-Rhino-Laryngology, 277, 2251-2261.
|
[16]
|
Fotuhi, M., Mian, A., Meysami, S. and Raji, C.A. (2020) Neurobiology of COVID-19. Journal of Alzheimer’s Disease: JAD, 76, 3-19. https://doi.org/10.3233/JAD-200581
|
[17]
|
Brann, J.H. and Firestein, S.J. (2014) A Lifetime of Neurogenesis in the Olfac-tory System. Frontiers in Neuroscience, 8, Article No. 182. https://doi.org/10.3389/fnins.2014.00182
|
[18]
|
Bilinska, K., Jakubowska, P., Von Bartheld, C.S. and Butowt, R. (2020) Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age. ACS Chemical Neuroscience, 11, 1555-1562. https://doi.org/10.1021/acschemneuro.0c00210
|
[19]
|
Merkler, A.E., Parikh, N.S., Mir, S., Gupta, A., Kamel, H., Lin, E., et al. (2020) Risk of Ischemic Stroke in Patients with Coronavirus Disease 2019 (COVID-19) vs Patients with Influenza. JAMA Neurology, 77, 1366-1372.
https://doi.org/10.1001/jamaneurol.2020.2730
|
[20]
|
Li, Y.N., Li, M., Wang, M.D., Zhou, Y.F., Chang, J., Xian, Y., et al. (2020) Acute Cerebrovascular Disease Following COVID-19: A Single Center, Retrospective, Observational Study. Stroke and Vascular Neurology, 5, 279-284.
|
[21]
|
Lee, M.-H., Perl, D.P., Nair, G., Li, W.X., Maric, D., Murray, H., et al. (2020) Micro-vascular Injury in the Brains of Patients with Covid-19. The New England Journal of Medicine, 384, 481-483.
|
[22]
|
Hosp, J.A., Dressing, A., Blazhenets, G., Bormann, T., Rau, A., Schwabenland, M., et al. (2021) Cognitive Impairment and Altered Cere-bral Glucose Metabolism in the Subacute Stage of COVID-19. Brain: A Journal of Neurology, 144, 1263-1276. https://doi.org/10.1093/brain/awab009
|
[23]
|
Brown, E.E., Kumar, S., Rajji, K.T., et al. (2020) Anticipating and Mitigating the Impact of the COVID-19 Pandemic on Alzheimer’s Disease and Related Dementias. The American Journal of Geriatric Psychiatry, 28, 712-721.
https://doi.org/10.1016/j.jagp.2020.04.010
|
[24]
|
Gutiérrez-Ortiz, C., Méndez-Guerrero, A., Rodrigo-Rey, S., San Ped-ro-Murillo, E., Bermejo-Guerrero, L., Gordo-Mañas, R., et al. (2020) Miller Fisher Syndrome and Polyneuritis Cranialis in COVID-19. Neurology, 95, e601-e605. https://doi.org/10.1212/WNL.0000000000009619
|
[25]
|
Li, M.-Y., Li, L., Zhang, Y. and Wang, X.-S. (2020) Expression of the SARS-CoV-2 Cell Receptor Gene ACE2 in a Wide Variety of Human Tissues. Infectious Diseases of Poverty, 9, Article No. 45.
https://doi.org/10.1186/s40249-020-00662-x
|
[26]
|
Moriguchi, T., Harii, N., Goto, J., et al. (2020) A First Case of Menin-gitis/Encephalitis Associated with SARS-Coronavirus-2. International Journal of Infectious Diseases, 94, 55-58.
https://doi.org/10.1016/j.ijid.2020.03.062
|
[27]
|
Mannan, A.B. (2021) Chronic Long-COVID Syndrome: A Protracted COVID-19 Illness with Neurological Dysfunctions. CNS Neuroscience & Therapeutics, 27, 1433-1436. https://doi.org/10.1111/cns.13737
|
[28]
|
Asadi‐Pooya, A.A., Akbari, A., Emami, A., et al. (2022) Long COVID Syn-drome‐Associated Brain Fog. Journal of Medical Virology, 94, 979-984. https://doi.org/10.1002/jmv.27404
|
[29]
|
Peghin, M., Palese, A., Venturini, M., et al. (2021) Post-COVID-19 Symptoms 6 Months after Acute Infection among Hospitalized and Non-Hospitalized Patients. Clinical Microbiology and Infection, 27, 1507-1513.
https://doi.org/10.1016/j.cmi.2021.05.033
|
[30]
|
Baig, M.A. (2020) Chronic COVID Syndrome: Need for an Appropriate Medical Terminology for Long-COVID and COVID Long-Haulers. Journal of Medical Virology, 93, 2555-2556. https://doi.org/10.1002/jmv.26624
|
[31]
|
Hampshire, A., Chatfield, D.A., MPhil, A.M., Jolly, A., Trender, W., Hellyer, P.J., et al. (2022) Multivariate Profile and Acute-Phase Correlates of Cognitive Deficits in a COVID-19 Hospitalised Cohort. EClin-icalMedicine, 47, Article ID: 101417. https://doi.org/10.1016/j.eclinm.2022.101417
|
[32]
|
Mandal, S., Barnett, J., Brill, S.E., et al. (2021) “Long-COVID”: A Cross-Sectional Study of Persisting Symptoms, Biomarker and Imaging Abnormalities Fol-lowing Hospitalisation for COVID-19. Thorax, 76, 396-398.
https://doi.org/10.1136/thoraxjnl-2020-215818
|
[33]
|
Morin, L., Savale, L., et al. (2021) Four-Month Clinical Status of a Cohort of Patients after Hospitalization for COVID-19. JAMA: The Journal of the American Medical Association, 325, 1525-1534.
https://doi.org/10.1001/jama.2021.3331
|
[34]
|
Taquet, M., Geddes, J.R., Husain, M., Luciano, S. and Harrison, P.J. (2021) 6-Month Neurological and Psychiatric Outcomes in 236 379 Survivors of COVID-19: A Retrospective Cohort Study Using Electronic Health Records. The Lancet Psychiatry, 8, 416-427. https://doi.org/10.1016/S2215-0366(21)00084-5
|
[35]
|
Taquet, M., Sillett, R., Zhu, L., et al. (2022) Neurological and Psy-chiatric Risk Trajectories after SARS-CoV-2 Infection: An Analysis of 2-Year Retrospective Cohort Studies Including 1284437 Patients. The Lancet Psychiatry, 9, 815-827. https://doi.org/10.1016/S2215-0366(22)00260-7
|
[36]
|
Lu, Y., Li, X., Geng, D., et al. (2020) Cerebral Micro-Structural Changes in COVID-19 Patients—An MRI-Based 3-Month Follow-Up Study. EClinicalMedicine, 25, Article ID: 100484. https://doi.org/10.1016/j.eclinm.2020.100484
|
[37]
|
Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., et al. (2020) Neurologic Features in Severe SARS-CoV-2 Infection. The New England Journal of Medicine, 382, 2268-2270.
https://doi.org/10.1056/NEJMc2008597
|
[38]
|
Hamming, I., Timens, W., Bulthuis, M.L.C., Lely, A.T., Navis, G.J. and Van Goor, H. (2004) Tissue Distribution of ACE2 Protein, the Functional Receptor for SARS Coronavirus. A First Step in Understanding SARS Pathogenesis. The Journal of Pathology, 203, 631-637. https://doi.org/10.1002/path.1570
|
[39]
|
Matschke, J., Lütgehetmann, M., Hagel, C., Sperhake, J.P., Schröder, A.S., Edler, C., et al. (2020) Neuropathology of Patients with COVID-19 in Germany: A Post-Mortem Case Series. The Lancet Neurology, 19, 919-929.
https://doi.org/10.1016/S1474-4422(20)30308-2
|
[40]
|
Politi, S.L., Salsano, E. and Grimaldi, M. (2020) Magnetic Reso-nance Imaging Alteration of the Brain in a Patient with Coronavirus Disease 2019 (COVID-19) and Anosmia. JAMA Neurology, 77, 1028-1029.
https://doi.org/10.1001/jamaneurol.2020.2125
|
[41]
|
Solomon, I.H., Normandin, E., Bhattacharyya, S., Mukerji, S.S., Keller, K., Ali, A.S., et al. (2020) Neuropathological Features of Covid-19. The New England Journal of Medicine, 383, 989-992. https://doi.org/10.1056/NEJMc2019373
|
[42]
|
Rutkai, I., Mayer, M.G., Hellmers, L.M., Ning, B., Huang, Z., Monjure, C.J., et al. (2022) Neuropathology and Virus in Brain of SARS-CoV-2 Infected Non-Human Primates. Nature Communica-tions, 13, Article No. 1745.
https://doi.org/10.1038/s41467-022-29440-z
|
[43]
|
Spudich, S. and Nath, A. (2022) Nervous System Consequences of COVID-19. Science (New York, N.Y.), 375, 267-269. https://doi.org/10.1126/science.abm2052
|
[44]
|
Wenzel, J., Lampe, J., Müller-Fielitz, H., Schuster, R., Zille, M., Müller, K., et al. (2021) The SARS-CoV-2 Main Protease Mpro Causes Microvas-cular Brain Pathology by Cleaving NEMO in Brain Endothelial Cells. Nature Neuroscience, 24, 1522-1533. https://doi.org/10.1038/s41593-021-00926-1
|
[45]
|
Wu, J. and Chen, J.Z. (2014) Innate Immune Sensing and Signaling of Cytosolic Nucleic Acids. Annual Review of Immunology, 32, 461-488. https://doi.org/10.1146/annurev-immunol-032713-120156
|
[46]
|
Kondylis, V., Kumari, S., Vlantis, K. and Pasparakis, M. (2017) The Interplay of IKK, NF-κB and RIPK1 Signaling in the Regulation of Cell Death, Tissue Homeostasis and Inflamma-tion. Immunological Reviews, 277, 113-127.
https://doi.org/10.1111/imr.12550
|
[47]
|
Zhao, Z. (1999) Molecular Mimicry by Herpes Simplex Virus-Type 1: Autoim-mune Disease after Viral Infection. Science, 279, 1344-1347. https://doi.org/10.1126/science.279.5355.1344
|
[48]
|
Qin, C., Zhou, L.Q., Hu, Z.W., Zhang, S.Q., Yang, S., Tao, Y., et al. (2020) Dysregulation of Immune Response in Patients with Coro-navirus 2019 (COVID-19) in Wuhan, China. Clinical Infectious Diseases, 71, 762-768.
https://doi.org/10.1093/cid/ciaa248
|
[49]
|
Wang, E.Y., Mao, T.Y., Klein, J., et al. (2021) Diverse Functional Autoantibodies in Patients with COVID-19. Nature, 595, 283-288.
|
[50]
|
Vlachoyiannopoulos, P.G., Magira, E., Alexopoulos, H., Jahaj, E., Theophilopoulou, K., Kotanidou, A., et al. (2020) Autoantibodies Related to Systemic Autoimmune Rheumatic Diseases in Se-verely Ill Patients with COVID-19. Annals of the Rheumatic Diseases, 79, 1661-1663. https://doi.org/10.1136/annrheumdis-2020-218009
|
[51]
|
Jose, R.J. (2020) COVID-19 Cytokine Storm: The Interplay be-tween Inflammation and Coagulation. The Lancet Respiratory Medicine, 8, E46-E47. https://doi.org/10.1016/S2213-2600(20)30216-2
|
[52]
|
Fernández-Castañeda, A., Lu, P.W., Geraghty, A.C., Song, E., Lee, M.-H., Wood, J., et al. (2022) Mild Respiratory COVID Can Cause Multi-Lineage Neural Cell and Myelin Dysregulation. Cell, 185, 2452-2468.
https://doi.org/10.1016/j.cell.2022.06.008
|
[53]
|
Nazarinia, D., Behzadifard, M., Gholampour, J., Karimi, R. and Gholampour, M. (2022) Eotaxin-1 (CCL11) in Neuroinflammatory Disorders and Possible Role in COVID-19 Neurologic Complications. Actaneurologica Belgica, 122, 865-869. https://doi.org/10.1007/s13760-022-01984-3
|
[54]
|
McAlpine, L.S., Zubair, A.S., Maran, I., Chojecka, P., Lleva, P., Jasne, A.S., et al. (2021) Ischemic Stroke, Inflammation, and Endotheliopathy in COVID-19 Patients. Stroke, 52, e233-e238.
https://doi.org/10.1161/STROKEAHA.120.031971
|
[55]
|
Spiezia, L., Boscolo, A., Poletto, F., Cerruti, L., Tiberio, I., Campello, E., et al. (2020) COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure. Thrombosis and Haemostasis, 120, 998-1000. https://doi.org/10.1055/s-0040-1710018
|
[56]
|
Nannoni, S., de Groot, R., Bell, S., et al. (2021) Stroke in COVID-19: A Systematic Review and Meta-Analysis. International Journal of Stroke: Official Journal of the International Stroke Society, 16, 137-149.
https://doi.org/10.1177/1747493020972922
|
[57]
|
Thakur, K.T., Miller, E.H., Glendinning, M.D., Al-Dalahmah, O., Banu, M.A., Boehme, A.K., et al. (2021) COVID-19 Neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital. Brain: A Journal of Neurology, 144, 2696-2708. https://doi.org/10.1093/brain/awab148
|
[58]
|
Monje, M. and Iwasaki, A. (2022) The Neurobiology of Long COVID. Neuron, 110, 3484-3496.
https://doi.org/10.1016/j.neuron.2022.10.006
|